Tulane University, officially the Tulane University of Louisiana, is a private research university in New Orleans, Louisiana. It was founded as a public medical college in 1834 and became a comprehensive university in 1847.

During the past decade, Tulane University conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 48 clinical trials were completed, i.e. on average, 59.3% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 31 clinical trials were completed. i.e. 79.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tulane University" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 14 trials, followed by "Tulane University" with 11 trials sponsored, "Gilead Sciences" with 7 trials sponsored, "University of North Carolina, Chapel Hill" with 6 trials sponsored and "Incyte Corporation" with 6 trials sponsored. Other sponsors include 104 different institutions and companies that sponsored additional 84 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tulane University" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 17 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 11 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 7 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 5 trials as a collaborator and "Tulane University" with 5 trials as a collaborator. Other collaborators include 154 different institutions and companies that were collaborators in the rest 138 trials.

According to Clinical.Site data, the most researched conditions in "Tulane University" are "HIV Infections" (16 trials), "Hemophilia A" (10 trials), "Hypertension" (8 trials), "Prostate Cancer" (8 trials) and "HIV Infection" (6 trials). Many other conditions were trialed in "Tulane University" in a lesser frequency.

Most popular intervention types in "Tulane University" are "Drug" (80 trials), "Other" (17 trials), "Behavioral" (12 trials), "Biological" (12 trials) and "Device" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Prednisone" (4 trials), "placebo" (4 trials), "Raltegravir" (3 trials) and "Standard of Care" (3 trials). Other intervention names were less common.

The vast majority of trials in "Tulane University" are 123 trials for "All" genders, 20 trials for "Male" genders and 9 trials for "Female" genders.

Currently, there are 43 active trials in "Tulane University". 1 are not yet recruiting, 29 are recruiting, 11 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 82 completed trials in Tulane University, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Tulane University, 12 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 24 trials that are defined as “Not Applicable".

Tulane University has several departments that took part in Clinical trials: "Tulane Cancer Center Office of Clinical Research" - 45 trials, "Tulane Cancer Center" - 38 trials, "Louisiana Comprehensive Hemophilia Care Ctr" - 5 trials, "Tulane University Heart and Vascular Institute" - 4 trials, "Tulane University - Tulane Medical Center - Pediatrics" - 4 trials, "Tulane Univ / Tulane / LSU Clinical Trials Unit" - 3 trials, "Tulane Univ Med Ctr / Infectious Diseases Sect" - 2 trials